BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15735736)

  • 1. HPV16 E5 protein disrupts the c-Cbl-EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes.
    Zhang B; Srirangam A; Potter DA; Roman A
    Oncogene; 2005 Apr; 24(15):2585-8. PubMed ID: 15735736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E5 protein of human papillomavirus type 16 protects human foreskin keratinocytes from UV B-irradiation-induced apoptosis.
    Zhang B; Spandau DF; Roman A
    J Virol; 2002 Jan; 76(1):220-31. PubMed ID: 11739687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serine mutations that abrogate ligand-induced ubiquitination and internalization of the EGF receptor do not affect c-Cbl association with the receptor.
    Oksvold MP; Thien CB; Widerberg J; Chantry A; Huitfeldt HS; Langdon WY
    Oncogene; 2003 Nov; 22(52):8509-18. PubMed ID: 14627991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct interaction of Cbl with pTyr 1045 of the EGF receptor (EGFR) is required to sort the EGFR to lysosomes for degradation.
    Grøvdal LM; Stang E; Sorkin A; Madshus IH
    Exp Cell Res; 2004 Nov; 300(2):388-95. PubMed ID: 15475003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of human papillomavirus 16 E5 to the 16 kDa subunit c (proteolipid) of the vacuolar H+-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation.
    Rodríguez MI; Finbow ME; Alonso A
    Oncogene; 2000 Aug; 19(33):3727-32. PubMed ID: 10949926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV16 E5 affects the KGFR/FGFR2b-mediated epithelial growth through alteration of the receptor expression, signaling and endocytic traffic.
    Belleudi F; Leone L; Purpura V; Cannella F; Scrofani C; Torrisi MR
    Oncogene; 2011 Dec; 30(50):4963-76. PubMed ID: 21625213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The E3 ubiquitin ligases RNF126 and Rabring7 regulate endosomal sorting of the epidermal growth factor receptor.
    Smith CJ; Berry DM; McGlade CJ
    J Cell Sci; 2013 Mar; 126(Pt 6):1366-80. PubMed ID: 23418353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes.
    Akerman GS; Tolleson WH; Brown KL; Zyzak LL; Mourateva E; Engin TS; Basaraba A; Coker AL; Creek KE; Pirisi L
    Cancer Res; 2001 May; 61(9):3837-43. PubMed ID: 11325860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smad7 Modulates Epidermal Growth Factor Receptor Turnover through Sequestration of c-Cbl.
    Ha Thi HT; Kim HY; Choi SW; Kang JM; Kim SJ; Hong S
    Mol Cell Biol; 2015 Aug; 35(16):2841-50. PubMed ID: 26055326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alix/AIP1 antagonizes epidermal growth factor receptor downregulation by the Cbl-SETA/CIN85 complex.
    Schmidt MHH; Hoeller D; Yu J; Furnari FB; Cavenee WK; Dikic I; Bögler O
    Mol Cell Biol; 2004 Oct; 24(20):8981-93. PubMed ID: 15456872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Cbl directs EGF receptors into an endocytic pathway that involves the ubiquitin-interacting motif of Eps15.
    de Melker AA; van der Horst G; Borst J
    J Cell Sci; 2004 Oct; 117(Pt 21):5001-12. PubMed ID: 15383614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-localization of activated EGF receptor and its signal transducers to multivesicular compartments downstream of early endosomes in response to EGF.
    Oksvold MP; Skarpen E; Wierød L; Paulsen RE; Huitfeldt HS
    Eur J Cell Biol; 2001 Apr; 80(4):285-94. PubMed ID: 11370743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RASopathy-associated CBL germline mutations cause aberrant ubiquitylation and trafficking of EGFR.
    Brand K; Kentsch H; Glashoff C; Rosenberger G
    Hum Mutat; 2014 Nov; 35(11):1372-81. PubMed ID: 25178484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor fate is controlled by Hrs tyrosine phosphorylation sites that regulate Hrs degradation.
    Stern KA; Visser Smit GD; Place TL; Winistorfer S; Piper RC; Lill NL
    Mol Cell Biol; 2007 Feb; 27(3):888-98. PubMed ID: 17101784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ubiquitination-mediated degradation of epidermal growth factor receptor].
    Xiu X; Lü ZM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):120-7. PubMed ID: 15782507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cbl-mediated ubiquitinylation is required for lysosomal sorting of epidermal growth factor receptor but is dispensable for endocytosis.
    Duan L; Miura Y; Dimri M; Majumder B; Dodge IL; Reddi AL; Ghosh A; Fernandes N; Zhou P; Mullane-Robinson K; Rao N; Donoghue S; Rogers RA; Bowtell D; Naramura M; Gu H; Band V; Band H
    J Biol Chem; 2003 Aug; 278(31):28950-60. PubMed ID: 12754251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative regulation of Lck by Cbl ubiquitin ligase.
    Rao N; Miyake S; Reddi AL; Douillard P; Ghosh AK; Dodge IL; Zhou P; Fernandes ND; Band H
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3794-9. PubMed ID: 11904433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies.
    Longva KE; Blystad FD; Stang E; Larsen AM; Johannessen LE; Madshus IH
    J Cell Biol; 2002 Mar; 156(5):843-54. PubMed ID: 11864992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Cbl-mediated ubiquitinylation is required for epidermal growth factor receptor exit from the early endosomes.
    Ravid T; Heidinger JM; Gee P; Khan EM; Goldkorn T
    J Biol Chem; 2004 Aug; 279(35):37153-62. PubMed ID: 15210722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Cbl mediates ubiquitination, degradation, and down-regulation of human protease-activated receptor 2.
    Jacob C; Cottrell GS; Gehringer D; Schmidlin F; Grady EF; Bunnett NW
    J Biol Chem; 2005 Apr; 280(16):16076-87. PubMed ID: 15708858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.